•  
  •  
  •  
  •  

2026-08-05 02:38:03

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore

Keywords Selected:  APIManufacturingFacility

Stock Report

  • Successful completion of USFDA inspection at Vizag facility
  • Apitoria Pharma Pvt Ltd receives 3 observations from USFDA for Unit-V
  • Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga
  • Lupin achieves GMP Certification from TGA Australia for Dabhasa API Facility
  • SMS Lifesciences India Ltd receives EIR with VAI status from USFDA for API facility at Kazipally
  • Zydus receives EIR for the API manufacturing facility at Ankleshwar
  • USFDA classifies Emcure Pharmaceuticals Ltd's API facility at Kurkumbh as VAI
  • Laurus Labs Limited receives EIR for API facility Unit-4
  • Apitoria Pharma Pvt Ltd's API manufacturing facility classified as VAI by USFDA
  • Aarti Drugs Ltd receives Form 483 with 7 observations from USFDA after inspection at API facility
  • Fermenta Biotech Ltd's API manufacturing facility receives certificate of EU GMP compliance
  • Laurus Labs concludes successful USFDA audit for API Manufacturing Facility at Hyderabad
  • U.S. FDA completes inspection of Lupin's Dabhasa Facility with No Observations
  • Dr. Reddy's Laboratories Ltd receives EIR from USFDA for API facility at Bollaram
  • Dr. Reddy's Laboratories Limited's API facility at Srikakulam completes USFDA inspection successfully
  • Lupin receives EIR from US FDA for its API Manufacturing Facility in Vizag
  • Ipca Laboratories Ltd gets Form 483 with 11 observations for API manufacturing facility at Ratlam
  • Dr. Reddy's Laboratories Limited updates on USFDA GMP inspection at Bollaram unit
  • Morepen Laboratories Ltd announces successful completion of USFDA inspection of API facility at Baddi
  • U.S. FDA Completes Inspection of Lupin's Vizag Facility with No Observations
  • SMS Lifesciences India Ltd receives EIR from USFDA for API manufacturing facility

Latest Post

  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025